Skip to main content
Clinical Trials/IRCT2014071918533N1
IRCT2014071918533N1
Completed
未知

Comparison of efficacy of Botulinium Toxin A plus Triamcinolone intralesional injection with intralesional injection of Triamcinolone alone for treatment of keloid

euronox company(Tehran reseller)0 sites20 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
keloid scar.
Sponsor
euronox company(Tehran reseller)
Enrollment
20
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
euronox company(Tehran reseller)

Eligibility Criteria

Inclusion Criteria

  • ]nclusion criteria:patients should have at least too keloids on the skin ;age between 15 and 45 years
  • Exclusion criteria:pregnant or breast feeding women ;neuromuscular jaunction diseases or receiving neuromuscular junction blocker agents

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials